Effects of Writing About Stressful Experiences on Symptom Reduction in Patients With Asthma or Rheumatoid Arthritis: A Randomized Trial
CONTEXT Nonpharmacological treatments with little patient cost or risk are useful supplements to pharmacotherapy in the treatment of patients with chronic illness. Research has demonstrated that writing about emotionally traumatic experiences has a surprisingly beneficial effect on symptom reports,...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 1999-04, Vol.281 (14), p.1304-1309 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | CONTEXT Nonpharmacological treatments with little
patient cost or risk are useful supplements to pharmacotherapy in the
treatment of patients with chronic illness. Research has demonstrated
that writing about emotionally traumatic experiences has a surprisingly
beneficial effect on symptom reports, well-being, and health care use
in healthy individuals. OBJECTIVE To determine if writing about stressful life experiences
affects disease status in patients with asthma or rheumatoid
arthritis using standardized quantitative outcome measures. DESIGN Randomized controlled trial conducted between October 1996
and December 1997. SETTING Outpatient community residents drawn from
private and institutional practice. PATIENTS Volunteer sample of 112 patients with asthma
(n=61) or rheumatoid arthritis (n=51)
received the intervention; 107 completed the study, 58 in the asthma
group and 49 in the rheumatoid arthritis group. INTERVENTION Patients were assigned to write either about the most
stressful event of their lives (n=71; 39 asthma, 32
rheumatoid arthritis) or about emotionally neutral topics
(n=41; 22 asthma, 19 rheumatoid arthritis) (the control
intervention). MAIN OUTCOME MEASURES Asthma patients were evaluated with
spirometry and rheumatoid arthritis patients were clinically examined
by a rheumatologist. Assessments were conducted at baseline and at 2
weeks and 2 months and 4 months after writing and were done blind to
experimental condition. RESULTS Of evaluable patients 4 months after treatment, asthma
patients in the experimental group showed improvements in lung function
(the mean percentage of predicted forced expiratory volume in 1 second
[FEV1] improved from 63.9% at baseline to 76.3% at the
4-month follow-up; P |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.281.14.1304 |